Skip to main content

Life Sciences & Biomedical News

March 27, 2012 Magnesium Elektron Announces Development of Bio-absorbable Alloys for Medical Implants
Magnesium Elektron, world leader in the development, manufacture and supply of high performance magnesium alloys, today gave details of its research activities in the area of bio-absorbable magnesium alloys for medical implants.
March 13, 2012 Epistem announces a three year collaboration with GlaxoSmithKline in fibrosis research
Epistem plc (LSE:EHP), the UK biotechnology and personalised medicine company, is pleased to announce a three year biomarker collaboration with GlaxoSmithKline in the field of fibrosis research. The collaboration will focus on identifying key characteristics of diseased fibrotic tissue on which Epistem will apply its proprietary RNA-Amp™ technology to facilitate building an in depth understanding of the disease.
January 24, 2012 SMERUD Medical Research CRO Group brings significant investment to Manchester
Smerud Medical Research International AS (www.smerud.com), a Norwegian Headquartered full service, clinical contract research organisation (CRO) has made a significant investment in its Manchester (UK) office by trebling its employee headcount and facilities for 2012.
January 16, 2012 Government advisor hails opportunities for life sciences investment in Greater Manchester
Government life sciences advisor, Chris Brinsmead, visited Manchester on Friday 13 January, to gain insight into the city’s leading life sciences and biomedical sector.
January 12, 2012 Chancellor George Osborne unveils UK’s first Airport City in Manchester
The Chancellor of the Exchequer, George Osborne, today unveiled plans for the development of a £659million Airport City the first of its kind in the UK at Manchester Airport in the North West of England.
January 11, 2012 Healthcare and nuclear science key conference themes for 2012
Healthcare and nuclear science look set to dominate the city’s conference calendar in 2012. Three national healthcare science conferences by the MS Society, British Dental Society and British Cardiovascular Society will bring a combined estimated 8,700 delegates and an economic impact of approximately £11.7m in April and May. The three conferences will be held at Manchester Central Convention Complex.
November 10, 2011 Epistem announces partnership with The University of Manchester
Epistem plc, the UK biotechnology and personalised medicine company, has announced a partnership with The University of Manchester.
September 26, 2011 Trimega tests first military Brazilian police hair samples for drugs at Manchester laboratory
Trimega Laboratories, one of the world’s leading companies for testing hair for substance abuse, has received its first batch of 350 hair samples from the Brazilian military police, for testing for evidence of drug use. The hair samples come from applicants to the police force, and Trimega will test them at its laboratory in Manchester.
July 25, 2011 Manchester surgeons first in the UK to use new aneurysm repair device
Vascular surgeons at Manchester Royal Infirmary (MRI) have carried out the first four operations in the UK to repair abdominal aortic aneurysms using a new stent device made by US company TriVascular Inc, designed to enable a much broader group of patients to benefit from minimally invasive surgery.
June 8, 2011 MIDAS Exceeds Annual Targets with over 3,000 Jobs Created by Projects in 2010-11
Manchester’s inward investment agency, MIDAS, has today released its end-of-year figures, which show the agency has once again exceeded targets - supporting the creation of 3,182 new jobs across Greater Manchester in 2010-11.